Trial and error: prognostic gene signature study design altered.
Tuma
Rabiya S
RS
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015982:Bias; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D016172:DNA Fingerprinting; D004273:DNA, Neoplasm / Q000032:analysis*; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008207:Lymphatic Metastasis; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D016017:Odds Ratio; D020411:Oligonucleotide Array Sequence Analysis; D011379:Prognosis; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D015203:Reproducibility of Results; D012107:Research Design / Q000592:standards; D018570:Risk Assessment
D004273:DNA, Neoplasm